Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Pigneux, Arnaud
[Clear All Filters]
2023
Dumas P-Y
,
Pigneux A
.
[Management of AML in the elderly].
Bull Cancer. 2023.
PubMed
Google Scholar
2022
Duployez N
,
Largeaud L
,
Duchmann M
,
Kim R
,
Rieunier J
,
Lambert J
,
Bidet A
,
Larcher L
,
Lemoine J
,
Delhommeau F
, et al.
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.
Blood. 2022.
PubMed
Google Scholar
Daver NG
,
Dail M
,
Garcia JS
,
Jonas BA
,
Yee KWL
,
Kelly KR
,
Vey N
,
Assouline S
,
Roboz GJ
,
Paolini S
, et al.
Venetoclax and idasanutlin in relapsed/refractory AML: a non-randomized, open-label phase 1b trial.
Blood. 2022.
PubMed
Google Scholar
2021
Bouvier A
,
Hamel J-F
,
Delaunay J
,
Delabesse E
,
Dumas P-Y
,
Ledoux MPierre
,
Peterlin P
,
Luquet I
,
Guepin GRoth
,
Bulabois CEric
, et al.
Molecular classification and prognosis in younger adults with acute myeloid leukemia patients and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: final results of the GOELAMS/FILO AML 2006-IR trial.
Eur J Haematol. 2021.
PubMed
Google Scholar
2020
Nehme A
,
Dakik H
,
Picou F
,
Cheok M
,
Preudhomme C
,
Dombret H
,
Lambert J
,
Gyan E
,
Pigneux A
,
Recher C
, et al.
Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signature.
Blood Adv. 2020;4(20):5322-5335.
PubMed
Google Scholar
Fenwarth L
,
Thomas X
,
de Botton S
,
Duployez N
,
Bourhis J-H
,
Lesieur A
,
Fortin G
,
Meslin P-A
,
Yakoub-Agha I
,
Sujobert P
, et al.
A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia.
Blood. 2020.
PubMed
Google Scholar
2014
Huguet F
,
Leguay T
,
Raffoux E
,
Rousselot P
,
Vey N
,
Pigneux A
,
Ifrah N
,
Dombret H
.
Clofarabine for the treatment of Adult Acute Lymphoid Leukemia A review article by the GRAALL intergroup.
Leuk Lymphoma. 2014:1-39.
PubMed
Google Scholar
Médiavilla C
,
Vigouroux S
,
Tabrizi R
,
Pigneux A
,
Duclos C
,
Mohr C
,
Robles M
,
Milpied N
.
Transient grade 3-4 acute hepatitis is a common complication of rabbit antithymocyte globulin (Thymoglobulin) administered before allogeneic stem cell transplantation.
Biol Blood Marrow Transplant. 2014.
PubMed
Google Scholar